Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for prevention and treatment of diabetes complications in type 2 diabetes
TCTR20140303003Phase 3Completed
- Sponsor
- Thailand Science Research and Innovation
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of curcumin in type 2 diabetes mellitus (T2DM), metabolic dysfunction-associated steatotic liver disease (MASLD), Cirrhosis, osteoporosis, sponsored by Thailand Science Research and Innovation. Started May 2014; status: completed.
02
Drugs
curcumin
03
Conditions
type 2 diabetes mellitus (T2DM)metabolic dysfunction-associated steatotic liver disease (MASLD)Cirrhosisosteoporosis
Beyond the preview
Go deeper on TCTR20140303003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20140303003.